Gut microbiome dysbiosis and inflammatory markers in severe COVID-19: links to atherosclerosis and potential therapeutic insights
Nayebali Ahmadi, Mohammad Javad Hossein Tehrani, Ashkan Alamdary, Rasul Moukhah, Rajab Mardani, Maryam Shahali · 2025
Read Gut microbiome dysbiosis and inflammatory markers in severe COVID-19: links to atherosclerosis and potential therapeutic insights by Nayebali Ahmadi, Mohammad Javad Hossein Tehrani, Ashkan Alamdary, Rasul Moukhah, Rajab Mardani, Maryam Shahali (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13083812.txt.
Description
Nayebali Ahmadi and five colleagues compare blood markers and gut bacteria in severe COVID-19, mild COVID-19, and healthy people. The virus is known to harm the heart and blood vessels over time. The team wanted signs that track how sick a patient is and how the gut shifts with the disease.
Ninety people took part: thirty in intensive care, thirty in regular wards, and thirty healthy controls. Severe cases ran much higher on a panel of inflammation markers. Their stool held far less of two helpful gut bacteria that make short-chain fats the gut lining needs. The authors link gut loss and inflammation to the vessel harm seen after severe infection.
Catalog record
| CREATOR | Nayebali Ahmadi, Mohammad Javad Hossein Tehrani, Ashkan Alamdary, Rasul Moukhah, Rajab Mardani, Maryam Shahali |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |